CSTONE PHARMACEUTICALS revenue breakdown overview

CSTONE PHARMACEUTICALS revenue for the last year amounted to 433.41 M HKD, the most of which — 441.50 M HKD — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 512.54 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought CSTONE PHARMACEUTICALS 318.06 M HKD, and the year before that — 409.11 M HKD.